Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
301
DELISTED
Exact Sciences
EXAS
| $192M | 0.07% |
3,875,327
+197,740
| +5% | +$8.08M |
|
302
L3Harris
LHX
$53.9B
| $192M | 0.07% |
921,778
+35,027
| +4% | +$7.9M |
|
303
Lennar Class A
LEN
$20.4B
| $191M | 0.07% |
2,185,492
-281,560
| -11% | -$22.8M |
|
304
iShares MSCI USA Quality Factor ETF
QUAL
$47.6B
| $191M | 0.07% |
1,677,138
+17,544
| +1% | +$1.99M |
|
305
Xylem
XYL
$28.2B
| $188M | 0.06% |
1,698,840
-84,176
| -5% | -$8.82M |
|
306
iShares Gold Trust
IAU
$65.8B
| $187M | 0.06% |
5,401,643
-35,860
| -0.7% | -$1.18M |
|
307
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.77B
| $186M | 0.06% |
5,085,497
+1,148,745
| +29% | +$41.4M |
|
|
EDR
308
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $186M | 0.06% |
8,250,809
+1,121,784
| +16% | +$23.9M |
|
309
SLB Ltd
SLB
$77B
| $185M | 0.06% |
3,465,790
+1,280,412
| +59% | +$63.8M |
|
310
Keurig Dr Pepper
KDP
$41.5B
| $185M | 0.06% |
5,192,330
+2,248,856
| +76% | +$84.3M |
|
311
iShares Russell 1000 Value ETF
IWD
$83.1B
| $185M | 0.06% |
1,216,650
+165,325
| +16% | +$24.7M |
|
312
Repligen
RGEN
$8.97B
| $184M | 0.06% |
1,084,468
-41,103
| -4% | -$7.46M |
|
|
HOLX
313
DELISTED
Hologic
HOLX
| $183M | 0.06% |
2,441,900
+389,428
| +19% | +$27.7M |
|
|
GTM
314
ZoomInfo Technologies
GTM
$1.23B
| $183M | 0.06% |
6,064,604
+3,406,851
| +128% | +$118M |
|
315
Jazz Pharmaceuticals
JAZZ
$16.8B
| $181M | 0.06% |
1,136,038
+129,662
| +13% | +$19M |
|
316
DexCom
DXCM
$31.4B
| $180M | 0.06% |
1,590,179
+790,411
| +99% | +$86.8M |
|
317
Realty Income
O
$58.4B
| $179M | 0.06% |
2,828,925
+920,590
| +48% | +$57.2M |
|
318
Constellation Brands
STZ
$22.5B
| $179M | 0.06% |
770,528
+16,113
| +2% | +$3.86M |
|
319
Pultegroup
PHM
$24.6B
| $178M | 0.06% |
3,914,164
-92,551
| -2% | -$3.9M |
|
320
Micron Technology
MU
$1T
| $178M | 0.06% |
3,559,642
-1,770,260
| -33% | -$96.9M |
|
321
Chemed
CHE
$7.15B
| $177M | 0.06% |
347,684
-47,117
| -12% | -$22.9M |
|
322
iShares Core MSCI Total International Stock ETF
IXUS
$59.5B
| $176M | 0.06% |
3,013,131
+162,484
| +6% | +$9.07M |
|
323
State Street SPDR MSCI EAFE StrategicFactors ETF
QEFA
$1.07B
| $176M | 0.06% |
2,744,293
-541,982
| -16% | -$33.4M |
|
324
Western Digital
WDC
$159B
| $176M | 0.06% |
7,368,280
-206,464
| -3% | -$5.45M |
|
325
iShares Russell 1000 ETF
IWB
$49.7B
| $175M | 0.06% |
810,392
+55,802
| +7% | +$11.8M |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.